Breaking AI & Tech News Analyzed

The Unlikely Footballer's Professional Debut Cristo Fernández, known for his role as Dani Rojas in the hit Apple TV+ show Ted Lasso, has taken his passion for football from the small screen to the professional soccer pitch. The 35-year-old actor has signed a contract with El Paso Locomotive FC, a team in the USL Championship, the second tier of American soccer. Fernández's Football Background Fernández's journey in football began in Mexico, where he played youth football before a knee injury forced him to step away from the sport at the age of 15. Despite his acting career taking off, Fernández continued to pursue his football dreams. This year, he trained with the Major League Soccer side Chicago Fire's reserves. The Road to El Paso Locomotive FC Before joining El Paso Locomotive FC, Fernández had a two-month trial with the club, which included a pre-season appearance. His determination and passion for the game caught the attention of the team's head coach, Junior Gonzalez. Fernández's addition to the roster is seen as a significant boost, adding another attacking threat to the team's forward line. What's Next for Fernández? El Paso Locomotive FC, founded in 2018, currently sits fourth in Group B of the USL Championship standings. With Fernández on board, the team aims to continue growing its positive culture and making strides in the league. For Fernández, this opportunity marks a new chapter in his life, one where he can combine his love for football with his experience as a professional athlete.

A new large‑scale randomized trial presented at the European Congress on Obesity in Istanbul indicates that the oral GLP‑1 antagonist orforglipron can help patients retain the majority of weight lost with injectable therapies such as tirzepatide (Mounjaro) and semaglutide (Wegovy).Trial Shows Oral Orforglipron Preserves Most Weight After Switching from InjectablesThe study, funded by Eli Lilly, followed 376 US patients who had been on tirzepatide or semaglutide injections for 72 weeks and then randomized them to a daily orforglipron tablet or placebo for an additional year.Participants were previously on weekly GLP‑1 jabs that typically produce 15‑20% body‑weight loss.After the injection phase, subjects were switched to oral therapy or placebo for 12 months.Primary endpoint: proportion of weight loss retained at 12 months.Quantitative Outcomes: 75% vs 49% Retention for Tirzepatide Users, 80% vs 38% for Semaglutide UsersWeight‑loss maintenance differed markedly between the pill and placebo groups:Tirzepatide cohort: 75% of lost weight retained with orforglipron vs 49% with placebo.Semaglutide cohort: 80% retained with the pill vs 38% with placebo.Secondary benefits—blood pressure, cholesterol, and glycaemic control—were also sustained in the pill arm.Implications for Obesity Management and Healthcare CostsExperts highlighted the broader significance:Dr Louis Aronne (Weill Cornell Medicine) emphasized that treating obesity directly can simultaneously improve glucose, lipid, and blood‑pressure metrics.Dr Marie Spreckley (University of Cambridge) noted patient preference for oral therapy due to convenience, storage, and lower cost.Dr Simon Cork (Anglia Ruskin University) warned that injectable GLP‑1 drugs, while highly effective, are expensive and limit long‑term accessibility for both private payers and the NHS.The findings suggest a potential shift toward oral agents that maintain efficacy while reducing financial and logistical burdens.Future Outlook: Oral GLP‑1 Therapies Could Redefine Chronic Obesity CareIf further trials confirm these results, orforglipron could become a cornerstone of chronic obesity management, enabling earlier intervention (BMI 25‑27) and possibly preventing progression to severe obesity.Regulators and payers will likely scrutinize cost‑effectiveness models, but the prospect of a cheap, daily tablet that sustains weight loss may reshape treatment algorithms worldwide.

The Incident at University of Central Florida Students at the University of Central Florida's 2026 graduation ceremony recently expressed their discontent with a speaker's comments on artificial intelligence (AI). Gloria Caulfield, a real estate development executive, was booed by the graduating class of 2026 when she likened the rise of AI to the next Industrial Revolution. Student Reactions and Concerns The crowd's reaction was immediate and loud, with Caulfield pausing, turning away from the podium, and throwing her hands up in the air. She responded by asking, "Woop, what happened?" and then nervously laughing, "OK, I struck a chord. May I finish?" The students' reaction reflects a broader anxiety about AI's impact on their future careers. A 2025 poll by the Institute of Politics at the Harvard Kennedy School found that a majority of recent college graduates view AI as a threat to their job prospects. The Impact of AI on Job Prospects The students' concerns are not unfounded. AI is transforming various industries, from graphic design to Hollywood and journalism. Tech CEOs have been slashing workforces, citing AI's ability to replace some jobs and boost efficiency. Industries outside Silicon Valley are also being affected by AI. Students are under pressure to choose majors that lead to AI-proof careers. The Future of AI and Education Caulfield's speech, despite the initial backlash, highlighted the importance of adapting to technological changes. She compared the current situation to when she finished college as the internet started taking off, noting that such technologies can be gamechangers for economic development and new businesses. The incident underscores the need for educational institutions to address AI-related anxieties among students. It also emphasizes the importance of preparing students for a future where AI will play a significant role.

Study Shows Fetal Exposure to Vegetable Flavours Influences Post‑Birth PreferencesThe research team gave pregnant volunteers powdered kale or carrot capsules during the third trimester and later measured their children’s facial reactions to the same smells. Reactions were recorded via ultrasound before birth, repeated at three weeks, and again when the children were about three years old.Methodology: Kale and Carrot Powder Capsules Administered to Expectant MothersParticipants were asked to swallow a capsule each day containing either kale or carrot powder. The study avoided large volumes of juice, which many volunteers found unpalatable, opting for a low‑cost capsule format.Capsules administered in late pregnancy (around 32 weeks gestation).Initial chemosensory response captured with ultrasound imaging.Follow‑up assessments at 3 weeks and 3 years post‑birth.Sample Size and Observed Reactions Reveal Early Flavor MemoryAlthough the cohort was modest, the findings were consistent:12 children were observed at age three.Infants exposed to carrot powder smiled when presented with a carrot scent and grimaced at kale, and vice‑versa for the kale group.The same preference pattern was evident in the ultrasound scans before birth.These results suggest that flavour exposure in utero can create a durable chemosensory memory.Potential Public‑Health Benefits of Early Dietary ConditioningIf replicated on a larger scale, the approach could offer a low‑cost strategy for improving population nutrition:Reducing childhood resistance to vegetables may lower long‑term risks of obesity and diet‑related diseases.Capsules are inexpensive and could be integrated into routine prenatal supplements.The concept is adaptable to different cultural diets, as noted by the researchers’ interest in fish‑rich Japanese diets.Next Steps: Larger Trials and Cross‑Cultural ApplicationsThe authors acknowledge the need for a bigger, funded study to confirm the effect across diverse populations. Future research aims to:Expand the sample size to hundreds of mother‑child pairs.Test additional flavours and odourants, including artificial sweeteners.Explore policy pathways for incorporating flavour‑exposure capsules into prenatal care guidelines.Published in Developmental Psychobiology, the paper titled “Do Human Fetuses Form Long‑Lasting Chemosensory Memories?” opens a new avenue for early nutritional interventions.

The Lead: Australia's Spin Strategy for World Cup RedemptionAustralia's women's cricket team has unveiled a squad for the T20 World Cup with a clear focus on spin bowling, featuring captain Sophie Molineux's return alongside world-class spinners Ashleigh Gardner, Alana King, and Georgia Wareham. The team aims to bounce back from recent semi-final exits in major tournaments with this strategic selection.The Spin Selection DilemmaThe return of a fully fit Sophie Molineux from a lower back issue has created a selection squeeze for Australia, who already boast a formidable spin trio. Molineux, who has succeeded retired captain Alyssa Healy, will be a lock in the side despite the abundance of spin options. Chief selector Shawn Flegler confirmed that all four spinners could potentially play in the same side, with conditions determining the final combination.The Spinners' CredentialsAustralia's spin options are exceptionally strong. Alana King took a record 7-18 against South Africa in last year's 50-over World Cup and was player of the series after collecting 23 wickets in last year's Ashes triumph. King returned to the side after being left out of the India tour and took five wickets at an average of 11 in the West Indies, conceding just 5.5 runs an over while bowling in the powerplay.The Pace Attack ChangesThe pace bowling options have seen changes, with 20-year-old left-arm quick Lucy Hamilton included in the 15-player squad, while Darcie Brown was the surprise omission. Hamilton, who debuted in all three formats for Australia in March, brings a rare left-arm pace option in women's cricket. Coach Shelley Nitschke praised Hamilton's ability to get good bounce and bowl a heavy ball, noting it's a real point of difference for the attack.Squad Composition and ExperienceThe squad blends experience with new energy. Ellyse Perry will feature in her 10th T20 World Cup, having been part of every edition since the inaugural tournament in 2009. Allrounder Nicola Carey returns after a three-year absence, while Grace Harris is back after being left out of the recent West Indies tour. Annabel Sutherland also returns after missing the West Indies tour.Tournament Preparation and OutlookAustralia will play five warm-up games in England and Wales before their T20 World Cup campaign begins against South Africa on June 13. They'll play three warm-up matches at Arundel Castle against South Africa, starting on May 31, before a pair of practice games against England in Cardiff. The team is motivated by recent semi-final exits in major tournaments and aims to perform better in those crucial moments.

The Abrupt End of Australia's Sprint CampaignKaden Groves, Australia's premier sprinting hope at the 2026 Giro d'Italia, has been forced to abandon the race due to injuries sustained in a mass crash during the opening stage in Bulgaria. The 27-year-old, who was aiming to surpass Caleb Ewan's 11 Grand Tour stage wins and move second on the Australian all-time winners' list, joins compatriot Jay Vine in exiting the race prematurely due to crash-related injuries.The Opening Stage Crash That Changed the RaceGroves was among several riders injured in a mass crash occurring just 600 meters from the finish line as the race opened in Bulgaria on Friday. Despite appearing bloodied and limping immediately after the incident, his team Alpecin Premier-Tech initially reported that he seemed "OK." However, it later became clear that the 10-time Grand Tour stage winner was suffering from shoulder and neck bruising that proved more serious than initially assessed."I didn't ride yesterday. I hope after a complete day off the sensations have improved. I'll take it day by day and see how things are on the climb. I don't need to risk anything," Groves said before his withdrawal, indicating the severity of his condition despite his initial description of the injuries as "just a few superficial scrapes all over my body."Australian Cycling Suffers Double BlowThe withdrawal of Groves compounds a difficult start to the Giro for Australian cycling, following Jay Vine's earlier exit due to concussion and a broken elbow suffered in a crash on stage two. The two high-profile departures significantly reduce Australia's representation in the race's competitive aspects.In the absence of their big name duo Mathieu van der Poel and Jasper Philipsen, the Belgian team had anointed Groves, who was wearing No 1 in the race, as their main sprinter. With his exit, Francesco Busato will now lead Alpecin's sprinting efforts, though 25-year-old Australian Jensen Plowright may also receive opportunities after finishing 18th on stage three.Race Dynamics Shift as Sprinters ExitThe absence of key sprinters has altered the competitive landscape of the Giro. Ecuador's Jhonatan Narvaez capitalized on the changing dynamics to win stage four, providing a welcome boost for Vine's UAE Team Emirates XRG. Orluis Aular (Movistar) finished second, while Giulio Ciccone took third place and claimed the race leader's pink jersey.Two Australian general classification contenders remain in the race, with Red Bull-BORA hansgrohe's co-leader Jai Hindley and Jayco AlUla's Ben O'Connor both sitting handily 10 seconds behind new race leader Ciccone, alongside pre-race favorite Jonas Vingegaard (Visma Lease-A Bike).The Challenge Ahead: Mountain Stages AwaitWith sprinters exiting the race, attention now shifts to the climbers as the Giro prepares for its most demanding stages. Wednesday's fifth stage features nearly 4000m of climbing on the 203km route from Praia a Mare to Potenza, a profile that could significantly shake up the general classification standings.For Groves, the withdrawal represents a setback in his quest to add to his career tally of 10 Grand Tour stage victories. The Australian had just returned after a break of more than two months with knee trouble following a crash in the Omloop Het Nieuwsblad race at the start of March, making this latest injury particularly frustrating for the 27-year-old sprinter.

ACCESS: Medicare’s First AI‑Enabled Outcome‑Based Payment Model Pair Team was announced on April 30 as one of 150 organizations accepted into ACCESS (Advancing Chronic Care with Effective, Scalable Solutions), a CMS initiative that launches on July 5. The program shifts reimbursement from traditional time‑based fees to payments tied to measurable health outcomes such as lower blood pressure or reduced pain, covering conditions like diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety. Revenue Scale and Funding Behind Pair Team Staff: roughly 850 clinical professionals, the largest community‑health workforce in California. Revenue: exceeds nine figures (>$100 million) annually. Capital raised: about $30 million from investors including Kleiner Perkins, Kraft Ventures, and Next Ventures. Patient reach: partnerships give access to ~500,000 potential patients, with a goal of 1 million within three years. Industry context: digital‑health funding hit its highest Q1 total since the pandemic, with AI firms capturing the bulk of new capital. How Outcome‑Based Payments Could Redefine Chronic Care Delivery The ACCESS model creates the first federal mechanism to pay for AI agents that monitor patients between visits, coordinate social services, and ensure medication adherence. Flora, Pair Team’s voice‑AI assistant, now handles 24/7 intake, referrals, and check‑ins, delivering hour‑long conversations that act as both clinical touchpoints and companionship for high‑needs patients. Peer‑reviewed research in the Journal of General Internal Medicine shows Pair Team’s community‑integrated approach cuts avoidable emergency and inpatient utilization, with one‑in‑four hospital visits and one‑in‑two ER visits averted for its members. Risks remain: the program funnels highly sensitive data into a federal system with a history of breaches, and past CMS innovation pilots have drawn criticism for increasing federal spending without delivering projected savings. What’s Next for AI‑First Health Providers Under ACCESS Batlivala argues that lower per‑patient reimbursement rates are intentional, forcing providers to adopt lean, AI‑driven operations. As the program scales, success will hinge on: Automating patient interactions to keep costs below payment thresholds. Demonstrating measurable outcome improvements across the covered chronic conditions. Managing data‑privacy concerns to maintain trust among vulnerable populations. Attracting additional capital as investors watch the first AI‑centric Medicare payment model unfold. If Pair Team and its peers can prove the model’s efficacy, ACCESS could become a template for nationwide AI‑enabled, outcome‑based reimbursement, reshaping how Medicare incentivizes technology in health care.

Jason Collins' Death Marks End of a Pioneering NBA JourneyJason Collins, the league’s first openly gay player, passed away on May 12, 2026 after an eight‑month battle with an aggressive brain tumor. The family announced his death, noting his impact as both a player and an ambassador for inclusion.Key Career Milestones and the Final BattleCollins spent 13 years in the NBA, suiting up for six franchises, most notably the Boston Celtics and the New Jersey Nets. In 2013, he publicly came out, a move that reshaped the league’s cultural landscape. In his final weeks, he was honored with the inaugural Bill Walton Global Champion Award at the Green Sports Alliance Summit, accepted on his behalf by his twin brother, former NBA player Jarron Collins.Numbers That Highlight a Life of ImpactAge at death: 47NBA tenure: 13 yearsTeams played for: 6Diagnosis: Stage 4 glioblastoma (extremely low survival rate)Duration of illness: 8 monthsRipple Effects on LGBTQ Representation and Health AwarenessCollins’ openness paved the way for greater LGBTQ visibility in professional sports, inspiring athletes to live authentically. His battle with glioblastoma also spotlights the need for heightened medical support and research funding for brain‑tumor patients within athletic communities.What This Means for Future Advocacy in SportsStakeholders are likely to amplify initiatives that combine diversity, equity, and inclusion (DEI) with health‑care advocacy. Expect more leagues to partner with medical charities, and for former players to use their platforms to champion both LGBTQ rights and neurological disease awareness.

A Sudden Tragedy Shocks the GrizzliesBrandon Clarke, the 29‑year‑old forward for the Memphis Grizzlies, was found dead at a home in California’s San Fernando Valley, the team announced on Tuesday. No cause of death has been released.Details of Clarke’s Passing and Career HighlightsClarke was born in Vancouver, Canada, and entered the NBA as the 21st overall pick in the 2019 draft, originally selected by the Oklahoma City Thunder before his rights were traded to Memphis on draft night. He spent his entire career with the Grizzlies, earning a spot on the NBA All‑Rookie First Team in 2020 after averaging 12.1 points and 5.9 rebounds in his debut season.Injuries—including knee, calf, Achilles issues—limited his availability; he appeared in only two games during the 2025‑26 season and has missed 174 of a possible 246 games over the past three seasons.Career Statistics and Recent Playing TimeAverage career: 10.2 points and 5.5 rebounds per game over seven seasons2025‑26 season: 2 games playedContract: multiyear extension signed in October 2022Ramifications for Memphis Grizzlies and the NBA CommunityThe Grizzlies issued a statement describing Clarke as “an outstanding teammate and an even better person,” while NBA Commissioner Adam Silver called him “a beloved teammate and leader.” The loss affects not only the roster but also the broader Memphis community, where Clarke was active in outreach.What Lies Ahead for the Grizzlies Without ClarkeWith Clarke’s contract still in effect, the team will need to address the roster spot and salary cap implications while seeking to fill the leadership void. The Grizzlies may look to develop younger forwards or explore trade options to maintain competitiveness in the Western Conference.